N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid.
Agglutinates of native chicken erythrocytes caused by influenza virus A/Aichi/2/68 (H3N2) at 4 degrees C were potently fused and lysed at low pH (optimum pH 5.3) at 37 degrees C. Exogenous gangliosides GM3 (Sia alpha 2-3Gal beta 1-4Glc beta 1-ceramide) and GM2 (GalNAc beta 1-4(Sia alpha 2-3)-Gal beta 1-4Glc beta 1-ceramide) were integrated into the membranes of chicken asialoerythrocytes within 5-min incubation at 37 degrees C. We found that the incorporation of ganglioside GM3 containing N-acetylneuraminic acid into asialoerythrocytes restored the biological responsiveness to the virus as established by agglutination at 4 degrees C and fusion and hemolysis at 37 degrees C at pH 5.3. Biological responsiveness of GM3-NeuAc-erythrocytes to the virus was considerably higher than that of GM3-NeuGc-erythrocytes under the same experimental conditions. Treatment of the GM3-NeuAc-erythrocytes with neuraminidase again resulted in the complete abolishment of the response to the virus. Erythrocytes containing GM2-NeuAc showed no detectable biological responses toward the virus. The above results indicate that the hemagglutinin of influenza virus A/Aichi/2/68 (H3N2) recognizes the sialyloligosaccharide chain of ganglioside GM3 as its receptor which mediates the adsorption and fusion process on the virus entry into the host cells and has more preferential specificity for binding to N-acetylneuraminic acid-containing GM3 than that to N-glycolyl type in the target cell membranes.
D000327:Adsorption; D000818:Animals; D002417:Cattle; D002459:Cell Fusion / Q000187:drug effects; D002645:Chickens; D004912:Erythrocytes / Q000378:metabolism / Q000382:microbiology*; D005679:G(M3) Ganglioside / Q000031:analogs & derivatives / Q000097:blood*; D005732:Gangliosides / Q000097:blood*; D006387:Hemagglutination, Viral / Q000187:drug effects; D006461:Hemolysis; D006801:Humans; D053122:Influenza A Virus, H3N2 Subtype; D009980:Influenza A virus / Q000502:physiology*; D009439:Neuraminidase / Q000494:pharmacology; D011991:Receptors, Virus / Q000502:physiology*; D012794:Sialic Acids / Q000097:blood
D005679:G(M3) Ganglioside; D005732:Gangliosides; D011991:Receptors, Virus; D012794:Sialic Acids; C044298:N-glycolylneuraminyllactosylceramide; D009439:Neuraminidase